SAFETY OF TO FACITINIB COMPARED TO BIOLOGICAL DMARDS IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE: OVERVIEW OF SYSTEMATIC REVIEWS

被引：0
|
作者：
Reyes, J. M. [1 ]
Rodriguez, A. [2 ]
机构：
[1] Pfizer SAS, Bogota, Colombia
[2] Univ Nacl Colombia, Bogota, Colombia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.887
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS2
引用
收藏
页码：A152 / A153
页数：4
相关论文
共 50 条
  • [1] EFFICACY OF TOFACITINIB IN COMBINATION WITH METHOTREXATE COMPARED TO BIOLOGICAL DMARDS IN COMBINATION WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE: OVERVIEW OF SYSTEMATIC REVIEW
    Reyes, J. M.
    Rodriguez, A.
    VALUE IN HEALTH, 2015, 18 (03) : A1555 - A1555
  • [2] SAFETY OF TOFACITINIB COMPARED TO BIOLOGICAL DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE: OVERVIEW OF SYSTEMATIC REVIEW
    Reyes Sanchez, J. M.
    Rodriguez, A. E.
    Prieto, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 262 - 262
  • [3] EFFICACY OF TOFACITINIB IN COMBINATION WITH METHOTREXATE COMPARED TO BIOLOGICAL DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN COMBINATION WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE: OVERVIEW OF SYSTEMATIC REVIEW
    Sanchez, J. M. Reyes
    Rodriguez, A. E.
    Prieto, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1064 - 1064
  • [4] COMPARISON OF TOFACITINIB SAFETY AND EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS, OR TO ONE OR MORE BIOLOGICAL DMARDS
    Charles-Schoeman, C.
    Kremer, J.
    Krishnaswami, S.
    Soma, K.
    Geier, J.
    Zhang, R.
    Strengholt, S.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 271 - 272
  • [5] Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic DMARDs and/or biological DMARDs: Data from a local registry
    Rosas, Jose
    Senabre-Gallego, Jose Miguel
    Santos-Soler, Gregorio
    Bernal, Jose Antonio
    Bas, Ana Pons
    REUMATOLOGIA CLINICA, 2022, 18 (03): : 188 - 189
  • [6] The efficacy and safety of abatacept or infliximab in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Becker, J. C.
    Li, T.
    Schiff, M.
    RHEUMATOLOGY, 2008, 47 : II14 - II15
  • [7] Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological DMARDs: Results at 60 Weeks
    Genovese, Mark
    Combe, Bernard
    Hall, Stephen
    Rubbert-Roth, Andrea
    Zhong, Sheng
    Meerwein, Sebastian
    Pangan, Aileen
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
    Buch, Maya H.
    Walker, David
    Edwards, Christopher J.
    Barry, Jane
    Akroyd, Laura
    Omoruyi, Edmund V. Ekoka
    Taylor, Peter C.
    RHEUMATOLOGY, 2024,
  • [9] Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Sakamaki, Yoshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S474 - S475
  • [10] Effect and Safety of Concomitant Methotrexate and Tacrolimus on Clinical Response of Abatacept in Rheumatoid Arthritis Patients with Prior Use of Biological Dmards.
    Takahashi, Nobunori
    Kojima, Toshihisa
    Hirano, Yuji
    Kanayama, Yasuhide
    Funahashi, Koji
    Ishiguro, Naoki
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S222 - S223
12345